Azitra, Inc.

AMEX:AZTR

Biotechnology

Healthcare
$1.53 +113.99%

+$0.82 today

Market cap
$92.72M
Beta
-1.04
P/E (TTM)
-1.2
EPS (TTM)
-$0.64
52W Low $0.05High $2.13

Volume 146.25M

Average 11.12M

AZTR Operating Cash Flow

Cash generated by the company's core business operations during the period.

Azitra, Inc.AMEX: AZTR

Operating Cash Flow · Q2 FY2026 · quarter ended Jun 2026

Operating cash flow growth accelerates

Q2 FY2026 operating cash flow of $3.29M (cash outflow) rose 16.9% year over year, ahead of the +1.4% change in trailing-twelve-month operating cash flow. Sequentially, it rose 32.9% from the prior quarter. Over 3 fiscal years it compounded at +10.4% a year.

Context

  • Operating cash flow grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +16.9% holds above the trailing-twelve-month pace of +1.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$3.29M+32.9% QoQ
Last fiscal yearDec 2025
-$11.22M+10.2% YoY
LTMJun 2026
-$11.11M+1.4% YoY
Operating Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+16.9%——
1 year+10.2%——
3-year CAGR+10.4%——
5-year CAGR——
10-year CAGR——

Operating Cash Flow history

USD · from the cash flow

Latest · FY2025
(11.22M) USD
Year-over-year change
-10.2%

Operating Cash Flow vs competitors

How AZTR compares with its peers on the latest reported figures

  • AZTR's LTM Jun 2026 operating cash flow of $11.11M is the smallest of the 2 companies compared; the peer median is $17.27M.
  • Its year-over-year change of +1.4% is the lowest of 2, against a peer median of +28.6%.
  • Over three fiscal years its annual growth of +10.4% compares with a peer median of +4.3%.
AZTR Competitors Peer median
Operating Cash Flow for AZTR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INDPIndaptus Therapeutics, Inc.LTM Mar 2026$17.27M +28.6%+4.3%—
AZTRAzitra, Inc.LTM Jun 2026$11.11M +1.4%+10.4%—
Peer median (excluding AZTR) $17.27M+28.6%+4.3%—

Competitors are the stored peer set for AZTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(8.94M)(10.68M)(11.28M)(8.97M)(10.96M)
Depreciation & Amortization84.77K405.98K425.55K448.24K453.14K
Deferred Income Tax00000
Stock-Based Compensation306.06K184.47K151.51K245.05K62.74K
Change in Working Capital646.35K310.76K(753.43K)(441.72K)(797.23K)
Accounts Receivables194.17K66.67K42.73K133.15K(39.4K)
Inventory00000
Accounts Payables282.98K420.75K(68.68K)(140.54K)0
Other Working Capital169.2K(176.66K)(727.48K)(434.33K)(757.83K)
Other Non-Cash Items(164.86K)1.43M4.1M(1.47M)12.58K
Operating Cash Flow(8.07M)(8.35M)(7.36M)(10.18M)(11.22M)
Capital Expenditures(652.28K)(341.01K)(318.26K)(379.25K)(186.06K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(206.14K)(303.66K)(291.72K)(370.68K)(158.7K)
Investing Cash Flow(652.28K)(336.76K)(318.26K)(379.25K)(182.91K)
Debt Repayment984.39K4.35M(7.39K)(14.6K)(16.06K)
Common Stock Issued005.99M13.35M9.03M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities8.48K(215.38K)0(18.38K)(96.86K)
Financing Cash Flow992.86K4.13M5.98M13.32M8.92M
Effect of Forex Changes00000
Net Change in Cash(7.73M)(4.55M)(1.7M)2.76M(2.49M)
Free Cash Flow(8.72M)(8.69M)(7.68M)(10.56M)(11.41M)

Azitra, Inc.

AMEX:AZTR

Intrinsic Alpha fair value

Locked

Current Price

$1.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.